A key aspect of how embryos create the cells which secrete insulin is revealed in a new study published tomorrow (18 May) in the Journal of Biological Chemistry. The researchers hope that their findings will enable the development of new therapies for diabetes, a condition caused by insufficient levels of insulin.
The research reveals that glucose plays a key role in enabling healthy beta cells, which secrete insulin, to develop in the pancreas of an embryo. Glucose prompts a gene called Neurogenin3 to switch on another gene, known as NeuroD, which is crucial for the normal development of beta cells. If glucose levels are low this gene is not switched on.
Insulin is the principal hormone that regulates the uptake of glucose and if the beta cells are unable to produce sufficient insulin, this can cause diabetes.
The scientists, from Imperial College London and an INSERM Unit at Necker Hospital, Paris, hope that understanding how to switch on the gene that produces beta cells could eventually enable researchers to create these cells from stem cells. They could then transplant beta cells into patients with type 1 diabetes. In this type of diabetes the immune system attacks patients' beta cells and at the moment few patients with the condition are able to have beta cell transplants, because the cells have to be taken from deceased donors.
The researchers also hope that scientists will be able to develop drug therapies that enhance the action of glucose and hence encourage the growth of healthy beta cells.
Professor Guy Rutter, from the Division of Medicine at Imperial College and one of the authors of the paper, said: "We hope that by demonstrating that an 'extrinsic' factor like glucose can regulate the way in which insulin secreting cells develop we may eventually be able to reverse defects in the growth of these cells in patients with diabetes. Research like ours is opening up whole new sets of targets for drug treatments."
The researchers reached their conclusions after conducting research on tissues cultured from the primordial pancreas of very young rat embryos. Using an in vitro system, rather than looking at cells in vivo, enables researchers to gain a greater understanding of when and how different genes are being switched on.
Source: Imperial College London
Related stories:
Treatment corrects severe insulin imbalance in animal studies
Researchers have used a drug to achieve normal levels of blood sugar in animals genetically engineered to have abnormally high insulin levels. If this approach succeeds in humans, it could become an innovative medicine for children with congenital hyperinsulinism, a rare but potentially devastating genetic disease in which insulin levels become dangerously high.
New discovery a step towards better diabetes treatment
In today's issue of the prestigious journal
Cell Metabolism Uppsala scientists are presenting new findings that shed light on the processes that determine the release of the blood sugar-lowering hormone insulin. The discovery is based on the development of image analysis methods that make possible the detailed study of events immediately inside the plasma membrane of the insulin-secreting cells.
Scientists show why cells starved of iron burn more glucose
Duke University Medical Center scientists have found a mechanism that allows cells starved of iron to shut down energy-making processes that depend on iron and use a less efficient pathway involving glucose. This metabolic reshuffling mechanism, found in yeast cells, helps explain how humans respond to iron deficiency, and may help with diabetes research as well.
New Link Between Obesity and Type 2 Diabetes: Researchers Discover New Way Fats Kill Beta-cells
Researchers at the University of British Columbia have discovered a new link between increased level of fat in the human body and Type 2 diabetes. Researchers believe this will open new fields in diabetes research and could lead to new therapies.
Discovery of new signal pathway important to diabetes research
Scientists at Karolinska Institutet in Sweden and Miami University have discovered that cells in the pancreas cooperate – signal – in a way hitherto unknown. The discovery can eventually be of significance to the treatment of diabetes.
Researchers identify gene that regulates glucose levels
In an effort to understand how genes work, a collaborative study which includes the University of Southern California (USC) has identified a gene that regulates glucose levels. The results, which will be published in the July issue of the
Journal of Clinical Investigation and is currently available online, may provide further understanding of the underlying causes of diabetes.
New mouse model mimics hyperglycemia, aids in diabetes research
UT Southwestern Medical Center researchers have genetically engineered a laboratory mouse in which pancreatic beta cells can regenerate after being induced to die. The new animal model's regenerative ability may provide future insights into improved treatments of diabetes, which affects millions of Americans.
New vaccine approach prevents/reverses diabetes in lab study
Results of study are published in Diabetes, a journal of the American Diabetes Association
Microspheres carrying targeted nucleic acid molecules fabricated in the laboratory have been shown to prevent and even reverse new-onset cases of type 1 diabetes in animal models. The results of these studies were reported by diabetes researchers at the John G. Rangos Sr. Research Center at Children’s Hospital of Pittsburgh of UPMC and Baxter Healthcare Corporation.